AVITA Medical (RCEL) said Sunday that it has received CE Mark approval for its RECELL GO device, enabling it to commence sales in Europe and other CE-marked markets.
The company said that it will now roll out the device in select European countries, including Germany, Italy, and the UK, in collaboration with burn centers and clinical partners.
RECELL GO helps doctors use a small sample of a patient's skin to create a cell suspension that promotes healing in burns and wounds, it added.